ijms-logo

Journal Browser

Journal Browser

Cutting-Edge Molecular Research in Autoimmunity

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 185

Special Issue Editor


E-Mail
Guest Editor
1. Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases—IRCAD, University of Eastern Piedmont, 28100 Novara, Italy
2. Center for Translational Research on Autoimmune and Allergic Disease—CAAD, Università del Piemonte Orientale, 28100 Novara, Italy
Interests: osteopontin; cancers; autoimmune diseases; inflammation; chronic diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cutting-edge molecular research in autoimmunity is a new scientific area that could transform our understanding and treatment of autoimmune diseases. At its core, this field delves into the intricate mechanisms underlying how the immune system, designed to protect the body, can mistakenly attack its own tissues. Researchers are leveraging sophisticated molecular techniques to pinpoint genetic predispositions, epigenetic modifications, and environmental triggers that contribute to autoimmune conditions.

Key areas of focus include identifying specific biomarkers that can predict disease onset or progression, unraveling the complex interplay of immune cells and signaling molecules, and developing targeted therapies that modulate immune responses with precision. Techniques such as genome-wide association studies (GWASs), single-cell RNA sequencing, advanced imaging technologies, and high-dimensional flow cytometry are driving breakthroughs in understanding disease pathogenesis at unprecedented levels of detail.

Moreover, cutting-edge research is paving the way for personalized medicine approaches, where treatments can be tailored to an individual’s genetic and molecular profile, potentially optimizing therapeutic outcomes and minimizing side effects. As these molecular insights continue to deepen, they offer hope for novel therapies that may one day provide effective management or even cures for autoimmune diseases, significantly improving millions of individuals’ quality of life worldwide.

This Special Issue welcomes submissions on the latest advancements in the molecular research of autoimmune diseases, particularly original research and review articles focusing on biomarker identification, immune cell and signaling molecule interactions, and the development of personalized therapeutic strategies. Through these high-quality contributions, we aim to foster scientific discoveries and applications in this promising field.

Dr. Davide Raineri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • autoimmunity
  • autoimmune diseases
  • multiple sclerosis
  • rheumatoid arthritis
  • lupus
  • type 1 diabetes
  • inflammatory bowel disease
  • biomarkers
  • immune cells
  • signaling molecules

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop